Table 3 Summary of genomic PCR, RT-PCR and MSP analysis
From: Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array
OSCC cell lines | Other SCC cell lines | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genomic PCR | Â | ||||||||||||||||
 | HSC2 | HSC3 | HSC4 | OSC4 | OSC5 | OSC6 | SCC9 | SCC25 | Ca9–22 | SAS | HO1-U1 | KB | KN | TE4 | TE8 | EBC1 | ME180 |
Exon 1 | Â | Â | Â | Â | Â | Â | Â | Â | HD | HD | Â | Â | 2/13 (15%) | Â | Â | Â | Â |
Exon 2 | Â | Â | Â | Â | Â | Â | Â | Â | HD | HD | Â | Â | 2/13 (15%) | Â | Â | Â | Â |
Exon 3 | Â | Â | Â | Â | Â | Â | Â | Â | HD | Â | Â | Â | 1/13 (7%) | Â | Â | Â | Â |
Exon 4 | Â | Â | Â | Â | Â | Â | Â | Â | HD | HD | HD | Â | 3/13 (23%) | Â | Â | Â | Â |
RT-PCR | |||||||||||||||||
 | HSC2 | HSC3 | HSC4 | OSC4 | OSC5 | OSC6 | SCC9 | SCC25 | Ca9–22 | SAS | HO1-U1 | KB | KN | TE4 | TE8 | EBC1 | ME180 |
Exon 2 | NE | Â | Â | Â | Â | Â | Â | Â | NE | NE | Â | Â | 3/13 (23%) | NE | Â | Â | Â |
Exon 3 | Â | Â | Â | Â | Â | Â | Â | Â | NE | NE | Â | Â | 2/13 (15%) | NE | Â | Â | Â |
Exon 3–4 |  |  |  |  |  |  |  |  | NE | NE |  |  | 2/13 (15%) | NE |  |  |  |
Methylation-specific PCR (+: methylated , −: unmethylated) | |||||||||||||||||
HSC2 | HSC3 | HSC4 | OSC4 | OSC5 | OSC6 | SCC9 | SCC25 | Ca9–22 | SAS | HO1-U1 | KB | KN | TE4 | TE8 | EBC1 | ME180 |  |
+ | − | − | − | − | − | − | − | − | + | + | − | − | + | − | − | − |  |
OSCC primary tumors | |||||||||||||||||
 | T1 | T2 | T3 | T4 | T5 | T6 | T7 | T8 | T9 | T10 |  |  |  |  |  |  |  |
Exon 1 | Â | HD | Â | HD | HD | Â | Â | HD | Â | HD | Â | Â | Â | Â | Â | Â | Â |
Exon 2 | HD | Â | Â | Â | Â | Â | HD | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Exon 3 | Â | Â | Â | Â | HD | HD | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Exon 4 | Â | Â | Â | HD | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | T11 | T12 | T13 | T14 | T15 | T16 | T17 | T18 | T19 | T20 |  |  |  |  |  |  |  |
Exon 1 | Â | HD | Â | Â | Â | Â | HD | HD | HD | Â | 9/20 (45%) | Â | Â | Â | Â | Â | Â |
Exon 2 | HD | HD | Â | Â | Â | Â | Â | Â | Â | Â | 4/20 (20%) | Â | Â | Â | Â | Â | Â |
Exon 3 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 2/20 (10%) | Â | Â | Â | Â | Â | Â |
Exon 4 | HD | HD | HD | HD | HD | HD | Â | Â | Â | Â | 7/20 (35%) | Â | Â | Â | Â | Â | Â |